For the second time in 15 months, Japanese ophthalmology specialist Santen has earned an FDA approval for its eye drops. The U.S. regulator has signed off on Santen’s Omlonti to reduce elevated ...

OSAKA, Japan--(BUSINESS WIRE)--Santen Pharmaceutical Co., Ltd. (“Santen”) announced today that Santen, in partnership with the International Agency for the Prevention of Blindness (IAPB), will take ...

MUNICH--(BUSINESS WIRE)--Santen GmbH. (Munich, Germany) (Santen) announced the positive outcome of the Decentralized Procedure (DCP) for TAPTIQOM® in Europe. The announcement follows the issuance of ...

OSAKA, Japan--(BUSINESS WIRE)--Santen Pharmaceutical Co., Ltd., (Osaka, Japan, Tokyo Stock Exchange: 4536) Japan's leading ophthalmic pharmaceutical company, announced today the appointment of Naveed ...

OSAKA, Japan--(BUSINESS WIRE)--Santen Pharmaceutical Co., Ltd. (hereafter Santen) announced today that it has signed licensing agreements and an asset transfer agreement with two U.S. companies.

Santen Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan, hereinafter Santen) and jCyte Inc. (Headquarters: Newport, California, US, hereinafter jCyte) announced the conclusion of an exclusive ...

Thinking about what to do with your Santen Pharmaceutical shares or whether now is the right time to jump in? You are not alone. The company’s journey over the past few years has definitely given ...

The RC28-E intravitreal injection is a dual-target fusion protein aimed at treating retinal diseases. Credit: Sai Thaw Kyar/Shutterstock.com. · Pharmaceutical Technology · Sai Thaw ...

Therapy indicated for children aged 3 to 14 at treatment initiation Santen has announced that the European Commission has granted market authorisation for Ryjunea, a low-dose atropine eye drop (0.1 mg ...

Add Yahoo as a preferred source to see more of our stories on Google. WHITEHOUSE STATION, N.J. (AP) -- Merck & Co. will receive at least $600 million in a deal with Japanese drugmaker Santen ...